
MD
Petar Simurdić
Physician in Residency
Phone021/4805210
Biography not provided.
Professional expertise/field
Karcinom bronha, invazivna dijagnostika, hemioterapija, imunoterapija, ciljana terapija
IASLC – International Association for the Study of Lung Cancer
ESMO – European Association of Medical Oncology
ESO – European School of Oncology
UMOS – Udruženje medilkalnih onkologa Srbije
SLD – Srpsko Lekarsko Društvo, Regionalna lekarska komora Vojvodine
UBS – Udruženje bronhologa Srbije
Stojsic V, Zaric B, Simurdic P, Kovacevic T, Bokan D, Djekic Malbasa J, Sarcev T, Stojanovic G, Bursac D, Nikolin B. Real world data – Survival outcomes of first line immunotherapywith pembrolizumab in high expressers with stage IV non-small cell lung cancer. Radiology and Oncology. Accepted for publication (May 2026.).
Zaric B, Djekic Malbasa J, Kovacevic T, Simurdic P, Stojšić V, Stojanovic G. Independent Predictors Associated with Patient Refusal of Invasive Diagnostic Procedures After Positive LDCT Lung Cancer Screening. Diagnostics. 2026; 16(5):709.
Stojanović M, Stojanović G, Simurdić P. Neželjena dejstva imunoterapije kod bolesnika obolelih od nesitnoćelijskog karcinoma pluća. Respiratio. 2024; 14: 56-65.
Kontić M, Marković F, Nikolić N, Samardžić N, Stojanović G, Simurdić P, Petkov S, Bursać D, Zarić B, Stjepanović M. Efficacy of Atezolizumab in Subsequent Lines of Therapy for NSCLC Patients: Insights from Real-World Data. Cancers. 2024; 16(21):3696.
Kovacevic T, Zaric B, Djekic Malbasa J, Bokan D, Nikolin B, Bursac D, Simurdic P, Stojsic V, Stojanovic G, Maric D. Attitudes toward Death among Health Care Professionals in the Balkan Region. Current Oncology. 2024; 31(6):3350-3360.
Bokan D, Zarić B, Kovačević T, Stojanović G, Simurdić P, Đekić Malbaša J. Geoprostorna analiza incidencije i mortaliteta od karcinoma bronha u okruzima AP Vojvodine. Respiratio. 2023; 13: 285-293.
Kovacevic T, Bokan D, Djekic Malbasa J, Zaric B, Bursac D, Stojanovic G, Simurdic P, Stojsic V. Influence of psychiatric disorders on survival in patients with lung cancer: Real-world dara. Annals of Oncology. 2023; 34: s1090.